Dr. Ostrosky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Fannin St
Ste 600
Houston, TX 77030Phone+1 713-500-6733Fax+1 713-500-5495- Is this information wrong?
Summary
- Luis Ostrosky-Zeichner, M.D., FACP, FIDSA, FSHEA, CMQ
Dr. Ostrosky-Zeichner is currently a professor of medicine and epidemiology, the Vice-Chair of Medicine for Healthcare Quality, and the director of the Laboratory of Mycology Research, at the Division of Infectious Diseases of the McGovern Medical School (a part of UTHealth). He also serves medical director for epidemiology and antimicrobial stewardship for Memorial Hermann Texas Medical Center. He is a fellow of the American College of Physicians, the Infectious Diseases Society of America, the Society of Healthcare Epidemiology of America, and the Academy of the European Confederation of Medical Mycology. He is a Senior Editor for Journal of Antimicrobial Chemotherapy, as well as an editorial board member of Antimicrobial Agents and Chemotherapy. He is a board member of the Mycoses Study Group and Educational Consortium and the International Immunocompromised Host Society. He is also a past chair of the Infectious Diseases Society of America Standards and Practice Guidelines Committee and a consultant to the US FDA and CDC.
Dr. Ostrosky-Zeichner obtained his medical degree from Universidad Nacional Autonoma de Mexico. He completed his internal medicine residency at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, and his infectious diseases fellowship at the University of Texas Medical School at Houston and MD Anderson Cancer Center combined fellowship program. He has advanced training and experience in medical mycology, healthcare epidemiology, antimicrobial stewardship, general and transplant infectious diseases, and healthcare quality and has published over 140 peer-reviewed articles on those topics.
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 1999 - 2002
- U Texas Med Sch1999 - 2002
- Universidad Nacional Autonoma de MexicoClass of 1995, Honors
Certifications & Licensure
- TX State Medical License 2002 - 2024
- American Board of Medical QualityCMQ
Awards, Honors, & Recognition
- Fellow European Confederation of Medical Mycology
- Fellow American College of Physicians
- Fellow Infectious Diseases Society of America
- Join now to see all
Clinical Trials
- Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) Start of enrollment: 2007 Aug 01
- Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment Start of enrollment: 2017 Apr 01
- CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients Start of enrollment: 2020 Apr 17
Publications & Presentations
PubMed
- 48 citationsEfficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.Mila B Ortigoza, Hyunah Yoon, Keith S Goldfeld, Andrea B Troxel, Johanna P Daily
JAMA Internal Medicine. 2022-02-01 - 390 citationsCombination Antifungal TherapyMelissa D. Johnson, Conan MacDougall, Luis Ostrosky-Zeichner, John R. Perfect, John H. Rex
Antimicrobial Agents and Chemotherapy. 2004-03-01 - 2048 citationsClinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of AmericaPeter G. Pappas, Carol A. Kauffman, David R. Andes, Cornelius J. Clancy, Kieren A. Marr
Clinical Infectious Diseases. 2016-02-15
Authored Content
- IDWeek 2018: Accuracy of the NHSN Central Line-Associated Bloodstream Infection DefinitionOctober 2018
- IDWeek 2018: Accuracy of the NHSN Central Line-Associated Bloodstream Infection DefinitionOctober 2018
- IDWeek 2018: Using Blockchain to Develop a Novel Propensity Score for Candidemia and Invasive CandidiasisOctober 2018
Press Mentions
- Texas Has One of the Lowest Vaccination Rates in the U.S. Here's WhySeptember 19th, 2024
- Do Expired COVID Tests Still Work?September 6th, 2024
- Sloth Fever Is in the U.S. — Texas Disease Specialist Explains What to KnowAugust 31st, 2024
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: